Chong Xu, Ph.D.
Partner
About
Chong is a Partner at F-Prime Capital. He focuses primarily on biopharmaceutical and medical technology sectors and works closely with the Eight Roads Ventures Asia team to manage portfolio companies and new investment opportunities in China. At F-Prime, Chong has been involved in a number of company formations including as a founding investor of Skyline Therapeutics, K36 Therapeutics, and RareStone Group. Prior to joining F-Prime in 2015, Chong was an associate in McKinsey and Company’s Boston office, a hedge fund healthcare equity analyst with Massif Partners and Affirmed Healthcare, and a researcher focusing on developmental neurobiology at Temasek Life Sciences Laboratory in Singapore.
Chong holds a Ph.D. in Cell Biology from University of Virginia and a MBA from Darden School of Business, University of Virginia. He received his B.S. in biology from Zhejiang University, China.
-
Adagene (Nasdaq: ADAG) is an antibody discovery and engineering company with proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody. Learn more at www.adagene.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Suzhou, China
-
Year Invested
2011
-
Team
-
-
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease-fighting power of small molecule payloads, Adcentrx strives to develop next-generation targeted therapies for improving patient treatment options. Learn more: https://www.adcentrx.com/
-
Category
- Therapeutics
-
Status
- Private
-
Location
San Diego, CA and Shanghai, China
-
Year Invested
2023
-
Team
-
-
Alternative Bio’s mission is to translate the discovery of novel protein synthesis regulatory nodes into first-in-class precision medicines to treat the most challenging cancers. The company’s vision is to establish itself as a global pioneer in this new research space as it advances breakthrough therapies to benefit cancer patients worldwide.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Singapore
-
Year Invested
2022
-
Team
-
-
b-ONE Ortho Corp. is an emerging orthopedic technology company dedicated to the development of innovative orthopedic healthcare solutions that restore patient mobility and improve surgical outcomes. Every day we are committed to becoming the most credible choice for orthopedic products worldwide. Learn more at http://www.b1.co/.
-
Category
- MedTech
-
Status
- Private
-
Location
Cedar Knolls, NJ
-
Year Invested
2018
-
Team
-
-
Zhejiang Bang Er Medical Investment Management Co., Ltd. is a leading private medical service provider that operates several private hospitals specializing in orthopedic care and related services in China. Learn more at www.zjbanger.com.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Zhejiang, China
-
Year Invested
2015
-
Team
-
-
Better Life Medical is a fully-integrated hearing aid manufacturer developing and commercializing novel digital programmable hearing aid solutions for the Chinese market. Learn more at www.goblm.com.cn/.
-
Category
- MedTech
-
Status
- Private
-
Location
Suzhou, China
-
Year Invested
2011
-
Team
-
-
BioRegen Biomedical is a fully integrated medical product company based on a proprietary technology platform. BioRegen is developing and commercializing high quality hyaluronic acid (“HA”) based products for the Chinese market. Learn more at www.bioregenmed.com.
-
Category
- MedTech
-
Status
- Private
-
Location
China
-
Year Invested
2010
-
Team
-
-
Eyebright Medical Technology Co., Ltd. (SHA: 688050) is an emerging leader in the ophthalmologic device market in China. Learn more at www.ebmedical.com.
-
Category
- MedTech
-
Status
- Public
-
Location
Beijing, China
-
Year Invested
2015
-
Team
-
-
FCB Health is a health insurance and services company that aims to resolve the longstanding financial burden of rising medical expenses in rural China.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Jiangsu, China
-
Year Invested
2019
-
Team
-
-
Gyenno is a digital health company based in Shenzhen, China that is developing a holistic specialty care platform to improve diagnosis, disease management, and clinical research in Parkinson’s Disease and other CNS disorders. Lean more at www.gyenno.com/index-en.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Shenzhen, China
-
Year Invested
2021
-
Team
-
-
Health Technology is a mobile platform for hospitals that connects patients, optimizes the patient’s hospital visit experience, and streamlines administrator workflow. Learn more at www.gzhc365.com.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Guangzhou, China
-
Year Invested
2016
-
Team
-
-
Innovent Biologics (1801.HK) has built a robust pipeline of innovative and commercially promising monoclonal antibodies and other biologics in the fields of oncology, ophthalmology, autoimmune, and cardiovascular diseases. Learn more at www.innoventbio.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Suzhou, China
-
Year Invested
2011
-
Team
-
-
Insilico specializes in artificial intelligence for drug discovery, biomarker development and aging research. Learn more at www.insilico.com.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Hong Kong
-
Year Invested
2019
-
Team
-
-
K36 Therapeutics was established with the mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies. Its vision is to create breakthrough therapies for the unmet medical needs of cancer patients worldwide.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Cambridge, MA
-
Year Invested
2021
-
Team
-
-
KnowYourself is a digital health company that is focused on promoting mental wellness in China.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Beijing, China
-
Year Invested
2021
-
Team
-
-
LenoMed is a company that develops and produces insulin pumps. Learn more at www.lenomed.com.cn.
-
Category
- MedTech
-
Status
- Private
-
Location
Shanghai, China
-
Year Invested
2018
-
Team
-
-
MediTrust Health is a provider of payment services for medical healthcare. The company is dedicated to helping patients solve their own medical payment problems through financial insurance, manage medical expenses more efficiently, and providing value to patients around medical finance, curative effect insurance, and drug benefits, helping patients manage their medical expenses. Learn more at www.meditrusthealth.com.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Shanghai, China
-
Year Invested
2017
-
Team
-
-
Nanos Medical develops, manufactures and markets minimally invasive interventional therapy medical devices in the field of ENT, cardiovascular and others. Learn more at www.nanosmedical.com.
-
Category
- MedTech
-
Status
- Private
-
Location
Shanghai, China
-
Year Invested
2019
-
Team
-
-
NeuroSmart is an operator of an education and research center focusing on autism. The company helps patients with autism through scientific research and early intervention application, providing families with a comprehensive scientific family intervention program.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Zhejiang, China
-
Year Invested
2021
-
Team
-
-
Orient Speech Therapy Limited (“OST”) is a Hong-Kong based healthcare services provider that operates a chain of private speech therapy clinics in China. Learn more at www.dfqy.com.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Hong Kong, China
-
Year Invested
2015
-
Team
-
-
Pediatrix Therapeutics is a pharmaceutical company focused on the field of pediatrics by developing and introducing effective and clinically proven children’s medicines to provide Chinese children and families with high-quality and affordable treatment options
-
Category
- Therapeutics
-
Status
- Private
-
Location
Shanghai, China
-
Year Invested
2020
-
Team
-
-
RareStone (formerly Citrine Medicine) is a rare disease-focused therapeutics company focused on the Greater China market that was co-founded by Eight Roads Ventures, F-Prime Capital and Vivo Capital. RareStone is dedicated to improving the lives of rare disease patients by making diagnosis and essential treatments available and accessible for those who need them. Learn more at www.rarestonegroup.com.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Shanghai, China
-
Year Invested
2020
-
Team
-
-
REDPINE is a medical technology company that provides complete solutions for medical business. It focuses on the research and development and production of single-use Class III medical devices, initially endoscopes for urology and gynecology. Learn more at en.gzredpine.com.
-
Category
- MedTech
-
Status
- Private
-
Location
Guangdong, China
-
Year Invested
2020
-
Team
-
-
Semma Therapeutics is a regenerative medicine company founded to develop transformative stem cell-derived therapies to provide a functional cure for patients with diabetes. This company was acquired by Vertex in 2019.
-
Category
- Therapeutics
-
Status
- Acquired
-
Location
Cambridge, MA
-
Year Invested
2014
-
Team
-
-
Silexon is an emerging AI-empowered technology company which aims to create an open AI platform for strategic collaboration in order to facilitate data-driven life science research and empower drug R&D process, and ultimately provide patients with greater access to innovative drugs for unmet medical needs. Learn more at www.silexon.tech.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Nanjing, China
-
Year Invested
2021
-
Team
-
-
Sironax is a developer of pharmaceuticals for inflammatory and neuro-degenerative diseases. The company researches apoptosis and other cell death pathways to develop quality pharmaceuticals, enabling healthcare professionals to prescribe advanced treatments to their patients.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Beijing, China
-
Year Invested
2019
-
Team
-
-
Skyline Therapeutics (formerly Geneception) is a fully-integrated gene and cell therapy based in Hangzhou and Shanghai, China. Founded by F-Prime Capital, Eight Roads Ventures China and Lilly Asia Ventures in 2018, Skyline’s mission is to become a preeminent gene and cell therapy company, working to deliver world-class therapeutics for patients in China and globally.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Hangzhou and Shanghai, China
-
Year Invested
2018
-
Team
-
-
Structure Therapeutics (NASDAQ: GPCR) is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Learn more at www.structuretx.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Shanghai, China & San Diego, CA
-
Year Invested
2019
-
Team
-
-
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven and physics-based high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution. Learn more at www.tandemai.com.
-
Category
- Therapeutics
-
Status
- Private
-
Location
Shanghai, China and New York, NY
-
Year Invested
2023
-
Team
-
-
Wanhu provides integrated pharmacy benefit management services in China to better manage drug use and control costs. Learn more at www.wanhuhealth.com.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
China
-
Year Invested
2017
-
Team
-
-
YS Biopharma (NASDAQ: YS), formerly YishengBio, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. Learn more at www.ysbiopharm.com.
-
Category
- Therapeutics
-
Status
- Public
-
Location
Beijing, China
-
Year Invested
2012
-
Team
-
-
Zeen Health is a health IT company developing prescription digital therapeutics (PDT) for various mental health disorders. Learn more at dtxalliance.org/members/zeenhealth/.
-
Category
- Health IT/Services
-
Status
- Private
-
Location
Shenzhen, China
-
Year Invested
2021
-
Team
-